Outsourcing of Clinical Trials and Non-Interventional Studies – Selection of CRO from a Data Management, Biostatistics, Medical Writing and Quality Management Perspective

Stefan Schinzel, Karlheinz Theobald, Friedbert Theis, Ferdinand Hundt & Marlis Herbold
Nowadays outsourcing of clinical trial activities by pharmaceutical companies (PCO) to clinical research organizations (CRO) is a relevant quality topic in this multi-billion dollar business (2004 data as reported in [ref:1]). The main reasons for outsourcing are Lack of in-house resources[for full text, please go to the a.m. URL]